Lexicon Pharmaceuticals LXRX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 1.35 | 114.84 | -0.04 | -12,188 | -13 | |
| 2025Q2 | 0.95 | 67.07 | 0.01 | 3,736 | 3 | |
| 2025Q1 | 0.46 | 109.46 | -0.07 | -25,679 | -25 | |
| 2024Q4 | 0.74 | 109.46 | -0.09 | -32,737 | -34 | |
| 2024Q3 | 1.57 | 105.72 | -0.17 | -63,693 | -65 | |
| 2024Q2 | 1.68 | 108.08 | -0.17 | -55,354 | -53 | |
| 2024Q1 | 2.40 | 104.34 | -0.20 | -45,333 | -48 | |
| 2023Q4 | 1.53 | 105.42 | -0.20 | -46,737 | -50 | |
| 2023Q3 | 1.09 | 106.44 | -0.21 | -49,631 | -51 | |
| 2023Q2 | 2.29 | 103.02 | -0.22 | -44,240 | -45 | |
| 2023Q1 | 2.43 | 103.42 | -0.17 | -31,142 | -32 | |
| 2022Q4 | 1.91 | 103.02 | -0.17 | -30,278 | -30 | |
| 2022Q3 | 2.40 | 102.54 | -0.13 | -23,095 | -23 | |
| 2022Q2 | 1.86 | 100.51 | -0.16 | -24,007 | -25 | |
| 2022Q1 | 2.09 | 100.06 | -0.16 | -23,380 | -23 | |
| 2021Q4 | 3.94 | 100.06 | -0.17 | -25,330 | -26 | |
| 2021Q3 | 4.81 | 100.05 | -0.16 | -22,962 | -23 | |
| 2021Q2 | 4.59 | 100.34 | -0.12 | -17,959 | -18 | |
| 2021Q1 | 5.87 | 100.23 | -0.15 | -20,839 | -21 | |
| 2020Q4 | 3.42 | 134.18 | -0.03 | -7,458 | -5 |